Form 8-K · Current report
Philip Morris International 8-K, filed Aug 24, 2026
- Filed
- CIK
- 0001413329
- Accession no.
- 0001628280-26-058513
Summary
Philip Morris International, through certain non-U.S. affiliates, has entered into a contract manufacturing arrangement for combustible cigarettes with Philip Morris USA, an operating company of Altria Group. PMI said the first shipments are expected to begin early in 2027 subject to operational readiness and regulatory requirements, that it does not expect a material impact on its 2026 financials, and that it has no plans to commercialize combustible cigarettes in the United States.
Key points
- The arrangement covers contract manufacturing of combustible cigarettes, with the first shipments expected to begin early in 2027, subject to operational readiness and applicable regulatory requirements.
- PMI said it does not expect a material impact from the arrangement on its 2026 financials.
- PMI stated it has not commercialized combustible cigarettes in the United States and has no plans to do so, and that the arrangement will not change that.
- The companies said they will continue to operate independently and remain responsible for their own commercialization, distribution and regulatory activities.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01. Regulation FD Disclosure. On August 24, 2026, Philip Morris International Inc. issued a press release announcing it has entered, through certain of its non-U.S. affiliates, into a contract manufacturing arrangement for combustible cigarettes with Philip Morris USA, an operating company of Altria Group Inc. The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference into this Item 7.01. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.